Pig liver trial offers temporary lifeline for liver failure patients
NCT ID NCT07429838
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study tests a genetically-modified pig liver used outside the body to temporarily take over liver functions for people with acute-on-chronic liver failure. About 20 adults who are not eligible for a transplant will receive this treatment for a short time. The goal is to check safety and see if it can help reduce toxins and improve liver function.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University of Wisconsin
Madison, Wisconsin, 53792, United States
-
Washington University
St Louis, Missouri, 63130, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Better crystal ball for liver crisis: new scores put to the test
- New liver support protocol could help patients avoid transplant
- Exosome therapy shows promise for liver crisis in small trial
- Smaller stent, bigger hope: new TIPS technique aims to prevent brain fog
- New liver dialysis machine could save lives in severe liver failure
- Stem cell injection aims to prevent deadly liver complication